Tricia advises Canadian and international businesses in the health-care, pharmaceutical, biotech, medical devices, cannabis, food & beverage, and cosmetic industries on acquisitions, commercial transactions, equity investments and roll-ups, joint ventures, intellectual property licensing arrangements, the acquisition and divestiture of products or technologies and regulatory issues relating to Health Canada requirements, data protection, privacy, and anti-spam matters. She has in-depth experience negotiating and drafting purchase and sale, clinical trial, research, manufacturing, quality assurance and intellectual property assignment, transfer, license, and commercialization agreements.